Van Houte Hans

EDGAR CIK 0001817217

Nurix Therapeutics, Inc. - NRIX

CFO
Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
6
($1.19) M
-56,347 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/03/2025
10b5-1
03/03/2025
Sell
-5,825 @ $14.49
($84,388) 33,724 (-14.73%) Direct
11/01/2024
10b5-1
11/01/2024
Sell
-3,546 @ $24.28
($86,083) 33,724 (-9.51%) Direct
08/26/2024
10b5-1
08/26/2024
Sell
-20,000 @ $25.22
($504,370) 31,002 (-39.21%) Direct
08/01/2024
10b5-1
08/01/2024
Sell
-3,477 @ $21.45
($74,576) 51,002 (-6.38%) Direct
06/20/2024
10b5-1
06/20/2024
Sell
-20,000 @ $20.01
($400,216) 48,333 (-29.27%) Direct
05/02/2024
10b5-1
05/02/2024
Sell
-3,499 @ $12.83
($44,878) 68,333 (-4.87%) Direct